This is a preview of subscription content, log in via an institution to check access.
References
Sandini M, Ruscic KJ, Ferrone CR, et al. Intraoperative dexamethasone decreases infectious complications after pancreaticoduodenectomy and is associated with long-term survival in pancreatic cancer. Ann Surg Oncol. 2018;25(13):4020–6.
Newhook TE, Soliz JM, Prakash LR, et al. Impact of intraoperative dexamethasone on surgical and oncologic outcomes for patients with resected pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-09013-4.
Lee AJ, Simoneau E, Chiang YJ, et al. Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing. HPB. 2019;21(9):1203–10.
Tzeng CW, Tran Cao HS, Lee JE, et al. Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. J Gastrointest Surg. 2014;18(1):16–25.
Nassour I, Winters SB, Hoehn R, et al. Long-term oncologic outcomes of robotic and open pancreatectomy in a national cohort of pancreatic adenocarcinoma. J Surg Oncol. 2020;122(2):234–42.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
The authors have no commercial interests to disclose and did not receive any financial or material support for this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Newhook, T.E., Tzeng, CW.D. ASO Author Reflections: Tumor Biology and Safe Surgery Remain Major Determinants of Survival After Resection of Pancreatic Adenocarcinoma. Ann Surg Oncol 28, 1570–1571 (2021). https://doi.org/10.1245/s10434-020-09087-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-09087-0